$175 Million is the total value of Soleus Capital Management, L.P.'s 61 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 93.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZYME | Buy | ZYMEWORKS INC | $15,179,000 | +595.6% | 420,836 | +584.0% | 8.65% | +240.8% |
| EPIX | Buy | ESSA PHARMA INC | $12,909,000 | +55.1% | 2,082,185 | +0.1% | 7.36% | -24.0% |
| ZYME | New | ZYMEWORKS INCput | $11,827,000 | – | 327,900 | +100.0% | 6.74% | – |
| ISEE | Buy | IVERIC BIO INC | $8,296,000 | +50.0% | 1,626,701 | +1.2% | 4.73% | -26.5% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $7,204,000 | – | 136,214 | +100.0% | 4.11% | – |
| PRTA | New | PROTHENA CORP PLC | $7,056,000 | – | 674,603 | +100.0% | 4.02% | – |
| QDEL | New | QUIDEL CORP | $6,913,000 | – | 30,900 | +100.0% | 3.94% | – |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $5,954,000 | +116.1% | 620,266 | +53.1% | 3.39% | +5.9% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $5,700,000 | +32.8% | 50,789 | +6.3% | 3.25% | -34.9% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $5,531,000 | – | 34,500 | +100.0% | 3.15% | – |
| IRMD | Sell | IRADIMED CORP | $4,930,000 | -1.7% | 212,436 | -9.5% | 2.81% | -51.8% |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $4,566,000 | +48.9% | 218,723 | -30.3% | 2.60% | -27.1% |
| ZYXI | Sell | ZYNEX INC | $4,390,000 | +13.8% | 176,541 | -49.4% | 2.50% | -44.3% |
| IMMU | New | IMMUNOMEDICS INC | $4,217,000 | – | 119,000 | +100.0% | 2.40% | – |
| DXCM | Sell | DEXCOM INC | $3,871,000 | +6.9% | 9,550 | -29.0% | 2.21% | -47.6% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $3,421,000 | +36.8% | 369,852 | -31.1% | 1.95% | -33.0% |
| LLY | New | LILLY ELI & CO | $3,414,000 | – | 20,800 | +100.0% | 1.95% | – |
| NVCR | Buy | NOVOCURE LTD | $3,344,000 | +787.0% | 56,397 | +907.6% | 1.91% | +334.2% |
| VCEL | Sell | VERICEL CORP | $3,296,000 | +2.0% | 238,532 | -32.3% | 1.88% | -50.0% |
| NARI | New | INARI MED INC | $3,188,000 | – | 65,817 | +100.0% | 1.82% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $3,146,000 | +1997.3% | 250,897 | +1796.7% | 1.79% | +925.1% |
| ABBV | Buy | ABBVIE INC | $2,837,000 | +40.5% | 28,900 | +9.1% | 1.62% | -31.2% |
| MSON | Sell | MISONIX INC | $2,663,000 | +18.6% | 196,301 | -17.6% | 1.52% | -41.9% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $2,613,000 | +93.1% | 140,524 | +22.3% | 1.49% | -5.3% |
| OSUR | New | ORASURE TECHNOLOGIES INC | $2,595,000 | – | 223,200 | +100.0% | 1.48% | – |
| HUM | New | HUMANA INC | $2,559,000 | – | 6,600 | +100.0% | 1.46% | – |
| NVRO | New | NEVRO CORP | $2,246,000 | – | 18,800 | +100.0% | 1.28% | – |
| IONS | New | IONIS PHARMACEUTICALS INC | $2,146,000 | – | 36,400 | +100.0% | 1.22% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $1,919,000 | +188.6% | 127,300 | +76.8% | 1.09% | +41.3% |
| SRDX | New | SURMODICS INC | $1,901,000 | – | 43,978 | +100.0% | 1.08% | – |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $1,713,000 | +7.0% | 48,800 | -22.5% | 0.98% | -47.6% |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $1,645,000 | – | 29,600 | +100.0% | 0.94% | – |
| RFL | Buy | RAFAEL HLDGS INC | $1,505,000 | +31.8% | 104,737 | +17.5% | 0.86% | -35.4% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $1,264,000 | +81.6% | 17,200 | +4.9% | 0.72% | -11.0% |
| STAA | Buy | STAAR SURGICAL CO | $1,257,000 | +398.8% | 20,428 | +162.0% | 0.72% | +144.7% |
| SILK | New | SILK RD MED INC | $1,160,000 | – | 27,711 | +100.0% | 0.66% | – |
| FATE | New | FATE THERAPEUTICS INC | $1,132,000 | – | 33,000 | +100.0% | 0.64% | – |
| KDMN | Sell | KADMON HLDGS INC | $1,028,000 | -4.5% | 200,841 | -21.9% | 0.59% | -53.2% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,023,000 | – | 14,000 | +100.0% | 0.58% | – |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $1,003,000 | +78.2% | 33,400 | +86.6% | 0.57% | -12.7% |
| New | GOSSAMER BIO INCnote 5.000% 6/0 | $1,001,000 | – | 1,000,000 | +100.0% | 0.57% | – | |
| VAPO | New | VAPOTHERM INC | $889,000 | – | 21,700 | +100.0% | 0.51% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $887,000 | – | 100,000 | +100.0% | 0.51% | – |
| PRVB | New | PROVENTION BIO INC | $845,000 | – | 59,900 | +100.0% | 0.48% | – |
| PODD | New | INSULET CORP | $777,000 | – | 4,000 | +100.0% | 0.44% | – |
| MASI | New | MASIMO CORP | $775,000 | – | 3,400 | +100.0% | 0.44% | – |
| AXGN | Buy | AXOGEN INC | $742,000 | -5.0% | 80,350 | +7.1% | 0.42% | -53.5% |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $695,000 | +294.9% | 28,469 | +139.9% | 0.40% | +93.2% |
| LYRA | New | LYRA THERAPEUTICS INC | $687,000 | – | 60,670 | +100.0% | 0.39% | – |
| PCRX | Buy | PACIRA BIOSCIENCES | $640,000 | +172.3% | 12,200 | +74.3% | 0.36% | +33.7% |
| ATRS | Sell | ANTARES PHARMA INC | $629,000 | -69.2% | 229,046 | -73.5% | 0.36% | -84.9% |
| BIIB | Sell | BIOGEN INC | $615,000 | -35.2% | 2,300 | -23.3% | 0.35% | -68.2% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $577,000 | +5.9% | 11,500 | +8.5% | 0.33% | -48.1% |
| CSTL | New | CASTLE BIOSCIENCES INC | $565,000 | – | 15,000 | +100.0% | 0.32% | – |
| HARP | Sell | HARPOON THERAPEUTICS INC | $512,000 | -90.6% | 30,886 | -93.4% | 0.29% | -95.4% |
| INSP | New | INSPIRE MED SYS INC | $488,000 | – | 5,608 | +100.0% | 0.28% | – |
| RAPT | New | RAPT THERAPEUTICS INC | $438,000 | – | 15,100 | +100.0% | 0.25% | – |
| LRMR | New | LARIMAR THERAPEUTICS INC | $400,000 | – | 31,170 | +100.0% | 0.23% | – |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $308,000 | -17.9% | 6,900 | -37.3% | 0.18% | -59.6% |
| ARVN | New | ARVINAS INC | $201,000 | – | 6,000 | +100.0% | 0.12% | – |
| INSMED INCnote 1.750% 1/1 | $174,000 | +16.0% | 180,000 | 0.0% | 0.10% | -43.4% | ||
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -19,000 | -100.0% | -0.23% | – |
| AYTU | Exit | AYTU BIOSCIENCE INC | $0 | – | -139,600 | -100.0% | -0.24% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -81,200 | -100.0% | -0.26% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -20,980 | -100.0% | -0.27% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -30,624 | -100.0% | -0.28% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -90,000 | -100.0% | -0.42% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -12,185 | -100.0% | -0.47% | – |
| LVGO | Exit | LIVONGO HEALTH INC | $0 | – | -18,100 | -100.0% | -0.60% | – |
| CTSO | Exit | CYTOSORBENTS CORP | $0 | – | -69,600 | -100.0% | -0.63% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -16,300 | -100.0% | -0.85% | – |
| MLND | Exit | MILLENDO THERAPEUTICS INC | $0 | – | -147,406 | -100.0% | -0.90% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -63,254 | -100.0% | -1.06% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -1,348,399 | -100.0% | -1.21% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -7,900 | -100.0% | -2.29% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -14,600 | -100.0% | -3.01% | – |
| GRFS | Exit | GRIFOLS S Asp adr rep b nvt | $0 | – | -387,035 | -100.0% | -9.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.